SCHEMBL25290715

SCHEMBL25290715

C=Cc1cc2nccnc2cc1Cl

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.37
▸ MEN1 O00255 3/20 0.33
▸ KMT2A Q03164 3/20 0.33
▸ HPGD P15428 2/20 0.33
▸ PKM P14618 1/20 0.33
▸ CASP6 P55212 1/20 0.32
▸ NPC1 O15118 3/20 0.32
▸ RAB9A P51151 3/20 0.32
▸ POLB P06746 1/20 0.31
▸ CASP3 P42574 1/20 0.31
▸ SENP7 Q9BQF6 1/20 0.31
▸ TTR P02766 1/20 0.30
▸ TDP1 Q9NUW8 1/20 0.30
▸ HTT P42858 1/20 0.30
▸ CYP1A2 P05177 1/20 0.30
▸ CYP2C9 P11712 1/20 0.30
▸ ALOX15 P16050 1/20 0.30
▸ CYP2C19 P33261 1/20 0.30
▸ HSD17B10 Q99714 1/20 0.30
▸ MAPK13 O15264 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31465323 1.00 ALDH1A1 (0.37) ALDH1A1MEN1KMT2AHPGDPKM
SCHEMBL25249080 0.78 TDP1 (0.48) ALDH1A1MEN1KMT2ACASP6NPC1
SCHEMBL1258350 0.75 CDK1 (0.48) MEN1KMT2ACASP6NPC1RAB9A
SCHEMBL9838335 0.75 ALDH1A1 (0.50) ALDH1A1TTRTDP1
SCHEMBL29944637 0.71 ALDH1A1 (0.46) ALDH1A1KDM4EL3MBTL1
SCHEMBL23275169 0.71 ALDH1A1 (0.46) ALDH1A1KDM4EL3MBTL1
SCHEMBL10780332 0.71 PDGFRB (0.34) ALDH1A1CYP2C9
SCHEMBL7079021 0.71 ALDH1A1 (0.46) ALDH1A1HPGDTTRTDP1HSD17B10
SCHEMBL29239899 0.67 ALDH1A1 (0.42) ALDH1A1POLBTTRTDP1
SCHEMBL31555805 0.67 ALDH1A1 (0.38) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250101436-A1 APTAMERS AND SMALL MOLECULE LIGANDS MeiraGTx Gene Regulation Limited (GB) 2025-03-27 — — US disclosed
EP-4448769-A2 APTAMERS AND SMALL MOLECULE LIGANDS Meiragtx UK II Limited (GB) 2024-10-23 — — EP disclosed
CN-118786217-A Aptamer and small molecule ligand 梅里特斯英国第二有限公司 2024-10-15 — — CN disclosed
WO-2023111686-A2 APTAMERS AND SMALL MOLECULE LIGANDS MEIRAGTX UK II LIMITED (GB) 2023-06-22 — — WO disclosed
WO-2023111686-A2 APTAMERS AND SMALL MOLECULE LIGANDS MEIRAGTX UK II LIMITED (GB) 2023-06-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250101436-A1 APTAMERS AND SMALL MOLECULE LIGANDS RNGTT, SLIRP, SNRPE ALDH1A1 2642/4885MEN1 4334/4885KMT2A 1917/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback